ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
66,579.62
-3.62%
S&P 500
5,267.84
-0.74%
Dow Jones
39,065.26
-1.53%
US Dollar vs Yen
156.916
0.13%
Brent Oil
81.125
-0.50%
Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Lexicon Pharmaceuticals Inc (LXRX)

  7. Lexicon Pharmaceuticals Inc (LXRX) ニュース

LXRX Lexicon Pharmaceuticals Inc

1.61
-0.065 (-3.88%)
最終更新日： 04:50:31
15分遅延
名称 銘柄コード 市場 種別
Lexicon Pharmaceuticals Inc LXRX NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
Upgrade Icon
-0.065 -3.88% 1.61 04:50:31
始値 安値 高値 終値 前日終値
1.68 1.585 1.68 1.675
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/5/1613:15EDGAR2Form EFFECT - Notice of Effectiveness
2024/5/1506:05EDGAR2Form SC 13D/A - General statement of acquisition of..
2024/5/1420:00GLOBENew Post-Hoc Analysis of Pooled Phase 3 Data Shows That..
2024/5/1405:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/5/1405:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/5/1405:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/5/1405:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/5/1405:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/5/1106:14EDGAR2Form S-3/A - Registration statement under Securities Act of..
2024/5/1105:15EDGAR2Form 8-K - Current report
2024/5/0920:30GLOBELexicon Pharmaceuticals to Participate in the Bank of..
2024/5/0305:05GLOBELexicon Pharmaceuticals Reports First Quarter 2024 Financial..
2024/4/2922:00GLOBELonnel Coats Retires as Chief Executive Officer and Board..
2024/4/2920:00GLOBELexicon Pharmaceuticals to Host First Quarter 2024 Financial..
2024/4/1821:00GLOBELexicon Pharmaceuticals to Host 2024 Investor Day
2024/4/0321:00GLOBELexicon Pharmaceuticals to Participate in the 23rd Annual..
2024/3/2522:20GLOBEClinical Data on the Impact of Sotagliflozin on Stroke and..
2024/3/1221:00GLOBENew Post Hoc Analysis of inTandem3 Study Demonstrates..
2024/3/1205:25EDGAR2Form PRE 14A - Other preliminary proxy statements
2024/3/1120:26EDGAR2Form 8-K - Current report
2024/3/1120:15GLOBELexicon Pharmaceuticals Reports Fourth Quarter..
2024/3/1120:05GLOBELexicon Announces Oversubscribed $250 Million Private..
2024/3/1120:00GLOBELexicon Preparing to Resubmit Sotagliflozin NDA for Type 1..
2024/3/0106:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0106:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1306:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1306:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1306:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1306:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1306:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1306:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1306:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1306:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1306:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0821:00GLOBELexicon Pharmaceuticals Provides Business and Pipeline..
2023/12/3007:29EDGAR2Form 8-K - Current report
2023/12/3007:27EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2023/12/3006:04EDGAR2Form 8-K - Current report
2023/12/2206:15GLOBELexicon Pharmaceuticals To Participate In The 42nd Annual..
2023/11/3021:30GLOBELexicon Enrolls First Patient in Phase 2b Progress Study of..
2023/11/2221:30GLOBELexicon Pharmaceuticals to Participate in the 35th Annual..
2023/11/1806:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/1407:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/1304:10GLOBEINPEFA® (sotagliflozin) Use Associated With Early Clinical..
2023/11/1106:01GLOBELexicon Pharmaceuticals to Participate in the Jefferies..
2023/11/0906:16EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/0821:22EDGAR2Form 8-K - Current report
2023/11/0821:00GLOBELexicon Pharmaceuticals Reports Third Quarter 2023 Financial..
2023/11/0322:00GLOBELexicon Pharmaceuticals to Host Third Quarter 2023 Financial..
2023/11/0222:00GLOBEData on Early Clinical Benefit for INPEFA® (Sotagliflozin)..

最近閲覧した銘柄

NASDAQ
LXRX
Lexicon Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

日本
会社情報
ビジネス
人気
アプリを入手

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有